Page 55 - รายงานประจำปี ๒๕๖๑-๖๒ คณะแพทยศาสตร์ มหาวิทยาลัยสงขลานครินทร์
P. 55

Survival  rate "llel-:i~tl1vvl-.;i1btl'U~e1-:i1~  ECMO



                         1.0

                                                       Organization  of
                         0.8
                                                       PSU  ECMO team

                         0 .6


                         0.4


                         0.2


                          0
                                  2014       2015        2016        2017        2018       2019

                               •   VA  Venoarterial   •  w  Venovenous  - - -  ELSO w  ECMO   - - -  ELSO  VA  ECMO









            el(Pl"a1fl1"a(Pl1V"llel-:i~tl1v  Sepsis  (Hospital Mortality)


                                                                                              .    Good
                      00S1nlSC11EJUOD'fil]JcJ
                        70
                        l,Q

                        50
                                                                       PCT  sepsis
                        40
                                                          Sepsis
                                                          campaign
                        30                             -------------------------
                        20
                        10

                         0                                                                              lasu1a /D
                             0   0   0   ..-  .-  ..--  NM  n   M   M   "'  ,q-  ,q-  \tl  Ill  Ill  \tl  -0   -0  .a  -0  r--  r-.  a,  a,   a,  CD   Cl'   0-  0-  0-  0   0   0   0   .-  ,...  .--  .-  N   N
                             \tl   II)  lfl   \fl  Ill  Ill   111   U')   \tl  \tl  \tl   \tl   II)   1/1   \tl  Ill  Ill  Ill  \tl   Ill  U'I  \tl   II)   Ill  \tl  \tl   \tl   \tl   1,/1  \tl   Ill  \tl  -0  -0  -0  .0   .0   .0  -0  ,a   -0  -0
                             I   I   I   I   I   I   '   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   I   l   I
                             N   M   ,q-  ,-  N   M   N   ,q-  .--  N   M   ,q-  "'<""NM.,,.--  NM..,.-  N  M   ,q-..-  N   M.,-  .--  n,   (')"frNM"f  .--  N(')"'   rN
                                                          .
                             ~~~i~~      ~   '8  '8   "0  'O  'O   ii ~i~ ._iii iii! i~  '8~"8  '8'8~~  '8'8~'8'8"8  ~  ~~~ ~~
                             !  &  !   0.  &  &   ~  &iii!   c.c.  & iio. a.o.C.  a.o.a.c.  o.o.  i&i i!&& &~&iil & ~&&  &&
                                        -- control   -- UCL    --   LCL   ----  Benchmarf1ing  global





                 vh.JU7'Vl7~ri~umrn.J1A1&1\9111~~(9)J'IJ1f111b'll  early  warning sign  b~ell'n6'l~5\9111m1mt1~tJ1rnk~bb\91U  2554 Vl~~•,nn
                                '                                                       "
            i1u1uTI  2559 1~t11 bnruo/1  NEWS  b~el 1vi&11m1riA'~me:i~~tJ1t1~&1~~t11~b11'11mb6'l:;i'.i  IV  Team  b~mtl~Vl6'lel~blfo~ b~el 1vi
                                                           "
            antibiotic 1~ b 11.ff u









          56    Arrual  Repor'  :=aculti,,  of Medic ne  2018-201'1
   50   51   52   53   54   55   56   57   58   59   60